Header Image
News Room / Biotechnology


RSS Feed

MorphoSys Announces That Its Licensee Janssen Has Initiated Two Phase 3 Studies with Tremfya(TM) (Guselkumab) in Psoriatic Arthritis
9/21/2017 -- 7:15 AM -- MorphoSys AG

U.S. Stem Cell Clinic Launches Blog To Educate Consumers On The Power Of Stem Cell Therapy
9/20/2017 -- 9:00 AM -- U.S. Stem Cell Clinic

BASi Strengthens Preclinical PK/PD Leadership With the Hiring of James E. Burleigh as Director of Operations, Preclinical PK/PD
9/19/2017 -- 8:17 AM -- Bioanalytical Systems, Inc.

Invitation to R&D Update of Molecular Partners AG on the DARPin(R) Difference - Offering Patients a New Dimension of Protein Therapeutics
9/19/2017 -- 1:00 AM -- Molecular Partners AG

Kane Biotech Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House
9/18/2017 -- 1:18 PM -- Kane Biotech Inc

AYOXXA Launches LUNARIS(TM) Mouse 12-Plex Th17 Kit to Elucidate Th17 Cell Biology
9/18/2017 -- 3:45 AM -- AYOXXA Biosystems GmbH

MorphoSys Announces that its Licensee Janssen received CHMP Positive Opinion for Tremfya(TM) (Guselkumab) Recommending Approval in Europe
9/18/2017 -- 2:10 AM -- MorphoSys AG

AYOXXA Introduces LUNARIS(TM), Its Advanced Fully Integrated Low-Volume Beads-on-a-Chip Multiplex Protein Analysis System
9/11/2017 -- 3:17 AM -- AYOXXA Biosystems GmbH

Rosetta Genomics Enters into Agreement to Sell Its PersonalizeDx Business to Pragmin Prognosis
9/8/2017 -- 8:30 AM -- Rosetta Genomics Ltd.

Molecular Partners to Present at the Morgan Stanley Global Healthcare Conference in New York
9/7/2017 -- 1:00 AM -- Molecular Partners AG

Lotus Bio-Technology Development Corp. Updates Shareholders on CBD Initiatives
9/6/2017 -- 10:00 AM -- Lotus Bio-Technology Development Corp.

Rosetta Genomics Expands Global Patent Protection for RosettaGX Reveal with Patent Allowance in Japan
9/6/2017 -- 8:30 AM -- Rosetta Genomics Ltd.

Rosetta Genomics to Reduce Operating and Other Expenses
9/5/2017 -- 8:30 AM -- Rosetta Genomics Ltd.

MorphoSys Presents Vision for Growth at its Capital Markets Day
9/5/2017 -- 5:15 AM -- MorphoSys AG

Molecular Partners Reports Key Financials and Corporate Highlights for H1 2017: Pipeline Development on Track with Several Key Milestones Ahead
8/30/2017 -- 1:00 AM -- Molecular Partners AG

Major Clinical Reference Laboratory Selects RosettaGX Reveal Thyroid miRNA Classifier as Molecular Test of Choice
8/21/2017 -- 8:00 AM -- Rosetta Genomics Ltd.

Lotus Bio-Technology Development Corp. Significantly Increases the Size of its Infrastructure and Farming Operation
8/17/2017 -- 8:25 AM -- Lotus Bio-Technology Development Corp.

MorphoSys to Present at Upcoming Investor Conferences
8/10/2017 -- 8:30 AM -- MorphoSys AG

Nexus BioPharma, Inc. Appoints Robert J. Neborsky, M.D. to Scientific and Clinical Advisory Board
8/10/2017 -- 8:00 AM -- Nexus BioPharma, Inc.

Vitro Biopharma Reports Positive Clinical Trial Results of Stem Cell Activation Therapy for Autism
8/8/2017 -- 9:30 AM -- Vitro Diagnostics, Inc.

American Cryostem Expands Acselerate Max(TM) Cell Culture Medium Patent Coverage
8/8/2017 -- 7:00 AM -- American CryoStem Corporation